Remove Engineering Remove Packaging Remove Regulations
article thumbnail

Q&A: One scientist’s bold vision to make on-demand treatments routine for life-threatening rare genetic diseases

Broad Institute

Doctors took donor T cells and performed three precise base edits on them, engineering them to attack leukemia cells while leaving healthy cells alone. Indeed, in 2022 Alyssa Tapley became the first human to receive a base-edited therapeutic, treating her life-threatening T-cell leukemia that had not responded to other treatments.

Treatment 133
article thumbnail

A Visual Guide to Genome Editors

Codon

pyogenes protein — whose compactness makes them far easier to package into viral vectors and deliver into the human body. Researchers have engineered more specific enzymes — possessing drastically reduced off-target effects — by altering either the structure of the Cas9 protein itself or its gRNA. Join Asimov Press.

DNA 81
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Levers for Biological Progress

Codon

Making a computer-designed protein in the laboratory requires, first, that scientists synthesize a string of DNA encoding the protein, insert that DNA into living cells, and then isolate the proteins churned out by the engineered cells. The world’s supply of insulin is now made by engineered microbes.

DNA 132
article thumbnail

Baxter Releases Annual Corporate Responsibility Report Highlighting Global Impact

The Pharma Data

This pilot effort included employee training on circularity principles and identified ways to apply these concepts to manufacturing and packaging. These frameworks ensure that stakeholders—from investors and employees to customers and regulators—have consistent and comprehensive access to data on Baxter’s ESG performance.

article thumbnail

Cas9 ancestor engineered into a compact genome editing tool

Broad Institute

Cas9 ancestor engineered into a compact genome editing tool By Tom Ulrich May 14, 2025 Breadcrumb Home Cas9 ancestor engineered into a compact genome editing tool Researchers adapt a compact RNA-guided enzyme from bacteria for a variety of DNA editing tasks in human cells.

article thumbnail

Epigenetic editing: the next generation of genetic medicine

Drug Target Review

The epigenome (meaning ‘above the genome’) is a system of reversible marks regulating how the DNA is read, translated and used. The molecular machinery of the epigenetic system can selectively package specific regions of DNA away, making them inaccessible and less active. The clinic is the natural next step for epigenetic editing.

DNA 105
article thumbnail

Mastering Responses to FDA 510(k) AI Letters: A Strategic Approach

FDA Law Blog: Biosimilars

Lenz, Principal Medical Device Regulation Expert — It takes a significant amount of time, cost, and effort to prepare a premarket notification 510(k) submission. Team meetings with subject matter experts can be scheduled to discuss response strategies for deficiencies that require extensive clinical, scientific, or engineering input.

FDA 75